Schonfeld Strategic Advisors »

Mineralys Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $554k 15k 37.92
2025-06-30 $3.4M 253k 13.53
2025-03-31 $3.5M 218k 15.88
2023-09-30 $1.8M 192k 9.51
2023-06-30 $2.0M 117k 17.05
2023-03-31 $1.4M 89k 15.66

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Ethereum Tr SHS (ETHA)
Fidelity Wise Origin Bitcoin SHS (FBTC)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
Alibaba Group Hldg Sponsored Ads (BABA)
Union Pacific Corporation (UNP)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Boston Scientific Corporation (BSX)

View all positions for Schonfeld Strategic Advisors

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
BlackRock
Vanguard Group
Caligan Partners
Capital Research and Management Company - Division 3
Citadel Advisors
Suvretta Capital Management
Sr One Capital Management
FMR
Franklin Resources
Point72 Asset Management
Laurion Capital Management
Farallon Capital Management

View all funds holding Mineralys Therapeutics